Geng-xi Jiang - Publications

GNGT1 remodels the tumor microenvironment and promotes immune escape through enhancing tumor stemness and modulating the fibrinogen beta chain-neutrophil extracellular trap signaling axis in lung adenocarcinoma.

Journal: Translational lung cancer research

Published: December 09, 2024

Outcomes of endoscopic submucosal dissection versus esophagectomy for poorly differentiated superficial esophageal squamous cell carcinoma: A 10-year cohort study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 02, 2024

Whole-exome and targeted gene sequencing of large-cell lung carcinoma reveals recurrent mutations in the PI3K pathway.

Journal: British journal of cancer

Published: December 23, 2022

Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma.

Journal: Frontiers in oncology

Published: April 18, 2022

Research Progress in Elucidating the Mechanisms Underlying Resveratrol Action on Lung Cancer.

Journal: Current pharmaceutical biotechnology

Published: January 02, 2022

MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer.

Journal: Technology in cancer research & treatment

Published: September 14, 2021

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer.

Journal: Molecular therapy oncolytics

Published: April 08, 2021

Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression.

Journal: Disease markers

Published: November 03, 2020

MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65.

Journal: Molecular therapy oncolytics

Published: October 31, 2020

microRNA-320b suppresses HNF4G and IGF2BP2 expression to inhibit angiogenesis and tumor growth of lung cancer.

Journal: Carcinogenesis

Published: October 13, 2020

Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma.

Journal: American journal of translational research

Published: May 14, 2020

High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1.

Journal: Oncotarget

Published: February 17, 2017